128 related articles for article (PubMed ID: 38013500)
1. Genome-wide CRISPR/Cas9 knockout screening to mitigate cell growth inhibition induced by histone deacetylase inhibitors in recombinant CHO cells.
Kim D; Kim SH; Yoon C; Lee GM
Biotechnol Bioeng; 2024 Mar; 121(3):931-941. PubMed ID: 38013500
[TBL] [Abstract][Full Text] [Related]
2. Small molecule epigenetic modulators for enhancing recombinant antibody production in CHO cell cultures.
Kim D; Yoon C; Lee GM
Biotechnol Bioeng; 2022 Mar; 119(3):820-831. PubMed ID: 34961935
[TBL] [Abstract][Full Text] [Related]
3. Identification of hyperosmotic stress-responsive genes in Chinese hamster ovary cells via genome-wide virus-free CRISPR/Cas9 screening.
Kim SH; Shin S; Baek M; Xiong K; Karottki KJC; Hefzi H; Grav LM; Pedersen LE; Kildegaard HF; Lewis NE; Lee JS; Lee GM
Metab Eng; 2023 Nov; 80():66-77. PubMed ID: 37709005
[TBL] [Abstract][Full Text] [Related]
4. Improving recombinant bone morphogenetic protein-4 (BMP-4) production by autoregulatory feedback loop removal using BMP receptor-knockout CHO cell lines.
Kim CL; Lee GM
Metab Eng; 2019 Mar; 52():57-67. PubMed ID: 30447330
[TBL] [Abstract][Full Text] [Related]
5. Knockout of sialidase and pro-apoptotic genes in Chinese hamster ovary cells enables the production of recombinant human erythropoietin in fed-batch cultures.
Ha TK; Hansen AH; Kildegaard HF; Lee GM
Metab Eng; 2020 Jan; 57():182-192. PubMed ID: 31785386
[TBL] [Abstract][Full Text] [Related]
6. CRISPR/Cas9-Mediated Knockout of MicroRNA-744 Improves Antibody Titer of CHO Production Cell Lines.
Raab N; Mathias S; Alt K; Handrick R; Fischer S; Schmieder V; Jadhav V; Borth N; Otte K
Biotechnol J; 2019 May; 14(5):e1800477. PubMed ID: 30802343
[TBL] [Abstract][Full Text] [Related]
7. Genome-Wide CRISPR/Cas9 Screening Unveils a Novel Target ATF7IP-SETDB1 Complex for Enhancing Difficult-to-Express Protein Production.
Kim SH; Park JH; Shin S; Shin S; Chun D; Kim YG; Yoo J; You WK; Lee JS; Lee GM
ACS Synth Biol; 2024 Feb; 13(2):634-647. PubMed ID: 38240694
[TBL] [Abstract][Full Text] [Related]
8. CRISPR/Cas9-mediated genome engineering of CHO cell factories: Application and perspectives.
Lee JS; Grav LM; Lewis NE; Faustrup Kildegaard H
Biotechnol J; 2015 Jul; 10(7):979-94. PubMed ID: 26058577
[TBL] [Abstract][Full Text] [Related]
9. Application of CRISPR/Cas9 Genome Editing to Improve Recombinant Protein Production in CHO Cells.
Grav LM; la Cour Karottki KJ; Lee JS; Kildegaard HF
Methods Mol Biol; 2017; 1603():101-118. PubMed ID: 28493126
[TBL] [Abstract][Full Text] [Related]
10. CRISPR/Cas12a-mediated CHO genome engineering can be effectively integrated at multiple stages of the cell line generation process for bioproduction.
Schweickert PG; Wang N; Sandefur SL; Lloyd ME; Konieczny SF; Frye CC; Cheng Z
Biotechnol J; 2021 Apr; 16(4):e2000308. PubMed ID: 33369118
[TBL] [Abstract][Full Text] [Related]
11. A CRISPR/Cas9 based engineering strategy for overexpression of multiple genes in Chinese hamster ovary cells.
Eisenhut P; Klanert G; Weinguny M; Baier L; Jadhav V; Ivansson D; Borth N
Metab Eng; 2018 Jul; 48():72-81. PubMed ID: 29852271
[TBL] [Abstract][Full Text] [Related]
12. Application of the CRISPR/Cas9 Gene Editing Method for Modulating Antibody Fucosylation in CHO Cells.
Wang Q; Aliyu L; Chung CY; Rosenberg JN; Yu G; Betenbaugh MJ
Methods Mol Biol; 2024; 2810():249-271. PubMed ID: 38926284
[TBL] [Abstract][Full Text] [Related]
13. Improving Antibody Production in Stably Transfected CHO Cells by CRISPR-Cas9-Mediated Inactivation of Genes Identified in a Large-Scale Screen with Chinese Hamster-Specific siRNAs.
Lin PC; Liu R; Alvin K; Wahyu S; Murgolo N; Ye J; Du Z; Song Z
Biotechnol J; 2021 Mar; 16(3):e2000267. PubMed ID: 33079482
[TBL] [Abstract][Full Text] [Related]
14. CRISPR Technologies in Chinese Hamster Ovary Cell Line Engineering.
Glinšek K; Bozovičar K; Bratkovič T
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175850
[TBL] [Abstract][Full Text] [Related]
15. Application of the CRISPR/Cas9 Gene Editing Method for Modulating Antibody Fucosylation in CHO Cells.
Wang Q; Chung CY; Rosenberg JN; Yu G; Betenbaugh MJ
Methods Mol Biol; 2018; 1850():237-257. PubMed ID: 30242691
[TBL] [Abstract][Full Text] [Related]
16. A ribonucleoprotein-based decaplex CRISPR/Cas9 knockout strategy for CHO host engineering.
Carver J; Kern M; Ko P; Greenwood-Goodwin M; Yu XC; Duan D; Tang D; Misaghi S; Auslaender S; Haley B; Yuk IH; Shen A
Biotechnol Prog; 2022 Jan; 38(1):e3212. PubMed ID: 34538022
[TBL] [Abstract][Full Text] [Related]
17. Accelerating genome editing in CHO cells using CRISPR Cas9 and CRISPy, a web-based target finding tool.
Ronda C; Pedersen LE; Hansen HG; Kallehauge TB; Betenbaugh MJ; Nielsen AT; Kildegaard HF
Biotechnol Bioeng; 2014 Aug; 111(8):1604-16. PubMed ID: 24827782
[TBL] [Abstract][Full Text] [Related]
18. Caspase-7 deficiency in Chinese hamster ovary cells reduces cell proliferation and viability.
Safari F; Farajnia S; Behzad Behbahani A; Zarredar H; Barekati-Mowahed M; Dehghani H
Biol Res; 2020 Nov; 53(1):52. PubMed ID: 33187557
[TBL] [Abstract][Full Text] [Related]
19. Targeted knock-in of an scFv-Fc antibody gene into the hprt locus of Chinese hamster ovary cells using CRISPR/Cas9 and CRIS-PITCh systems.
Kawabe Y; Komatsu S; Komatsu S; Murakami M; Ito A; Sakuma T; Nakamura T; Yamamoto T; Kamihira M
J Biosci Bioeng; 2018 May; 125(5):599-605. PubMed ID: 29295784
[TBL] [Abstract][Full Text] [Related]
20. Targeting miRNAs with CRISPR/Cas9 to Improve Recombinant Protein Production of CHO Cells.
Kellner K; Solanki A; Amann T; Lao N; Barron N
Methods Mol Biol; 2018; 1850():221-235. PubMed ID: 30242690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
